成熟的三级淋巴体结构相关的CD103+CD8+Trm细胞确定了乳腺癌中改善的抗瘤免疫力
Qin Fang1, Shuru Chen1, Xiaoyue Chen1
1Huizhou Central People's Hospital, Huizhou, China.
Frontiers in oncology
|February 10, 2025
概括
乳腺癌中的三级淋巴体结构 (TLS) 与更好的结果有关. 成熟的TLS含有更多的CD8+CD103+T细胞和NK细胞,增强抗瘤免疫力和预后.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 三级淋巴体结构 (TLS) 在固体瘤中对抗瘤免疫是至关重要的.
- 它们在增强抗瘤反应,特别是乳腺癌中的精确作用需要进一步阐明.
- 了解TLS成熟度和免疫细胞组成是改善癌症治疗的关键.
研究的目的:
- 研究TLS成熟度和乳腺癌中关键免疫细胞之间的关系.
- 确定乳腺癌患者TLS和相关免疫细胞的预后价值.
主要方法:
- 免疫光和H&E染色被用于分析TLS成熟度和免疫细胞群.
- 该研究包括95名乳腺癌患者的注释队列.
- 在TLS中评估了瘤内存T细胞 (Trm) 和NK细胞的分布和比例.
主要成果:
- TLS存在与改善乳腺癌预后相关.
- 与瘤外围相比,在TLS内发现CD8+CD103+Trm细胞和NK细胞的比例更高.
- TLS成熟与增加的CD103+CD8+Trm和NK细胞比例以及增强的效应器功能有关.
结论:
- TLS,特别是CD103+CD8+Trm细胞和NK细胞,为乳腺癌提供预后信息.
- TLS的成熟度与这些关键免疫细胞的增强效应器功能直接相关.
- 准TLS成熟可能代表乳腺癌的新疗法策略.
相关概念视频
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.


